Invitae Expects to Raise at Least $171M in Common Stock Offering

Mar 06, 2019

|

NEW YORK (GenomeWeb) – Invitae announced after the close of the market on Tuesday that it will sell 9 million shares of its common stock at $19.00 per share.

The public offering, which Invitae announced on Monday, is expected to close on or around March 8 and bring in $171.0 million in gross proceeds, the firm said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Invitae Expects to Raise at Least $171M in Common Stock Offering

To read the full story....

Breaking News

Zymo Research Gets CE-IVD Mark for Sample Collection Devices

Angle Files De Novo FDA Submission for CTC Collection Device in Breast Cancer

LabCorp, Genfit Partner to Commercialize Liver Disease Diagnostic Test

FDA Reissues Emergency Use Authorization for Hologic SARS-CoV-2 Assay for Asymptomatic Testing

Quotient Limited Gets FDA Emergency Use Authorization for Coronavirus Antibody Test

Palmetto Expands Coverage for Decipher Biosciences Prostate Cancer Test

What's Popular?

Quotient Limited Gets FDA Emergency Use Authorization for Coronavirus Antibody Test

LabCorp, Genfit Partner to Commercialize Liver Disease Diagnostic Test

FDA Grants Emergency Use Authorization for Jiangsu Well Biotech Coronavirus Antibody Test

Exact Sciences Stock Soars on New Data Around Pan-Cancer Liquid Biopsy Test

Angle Files De Novo FDA Submission for CTC Collection Device in Breast Cancer

Sponsorships